The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,328.00
Bid: 2,035.00
Ask: 2,430.00
Change: 0.00 (0.00%)
Spread: 395.00 (19.41%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,328.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Group Chief Executive succession

16 Jun 2022 07:01

RNS Number : 1104P
Halma PLC
16 June 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Halma plc ("Halma")

Group Chief Executive succession

Halma, the global group of life-saving technology companies, today announces that Andrew Williams has decided to retire as Group Chief Executive next year, after 18 years in the role. He will be succeeded by Marc Ronchetti, Chief Financial Officer, who is today appointed as Chief Executive Designate.

Andrew joined Halma in 1994 and was appointed Chief Executive in 2005. Since then, the Group has delivered consistently strong returns for its shareholders. Under Andrew's leadership, Halma's revenues have grown from less than £300m to more than £1.5bn today and has grown into a FTSE 100 global group of around 45 life-saving technology companies.

Marc joined Halma in 2016 as Group Financial Controller and was appointed as Chief Financial Officer in 2018. Marc has played a vital role in protecting and evolving the elements of Halma's Sustainable Growth Model, articulating its purpose and culture, and overseeing around 30 acquisitions.

Before Halma, Marc was Finance Director of the UK operations of Wolseley plc (now Ferguson plc) and prior to that held various group and divisional roles at Inchcape plc.

Marc will continue as Chief Financial Officer, in addition to becoming Chief Executive Designate, until his successor is appointed. Andrew will continue as Halma's Group Chief Executive and support Marc through the transition process until he takes over as Group Chief Executive on 1 April 2023. A search is underway to identify and appoint a successor to Marc as Chief Financial Officer.

Dame Louise Makin, Chair of Halma, said: "Andrew is an outstanding leader who has delivered exceptional value for our stakeholders and transformed Halma into one of Britain's Most Admired Companies. He will leave a strong, resilient, and agile Group, well placed to address the many opportunities in its markets and deliver superior and sustainable growth through its Sustainable Growth Model. I'd like to thank him personally, and on behalf of the Board, for his substantial contribution to Halma.

"After a rigorous selection process, I am delighted that Marc will become Halma's 4th Chief Executive in 50 years. I look forward to working with him to build on the momentum in the business."

Andrew said: "It is testament to Halma's long-term approach to succession planning and the quality of the Halma senior leadership team that the next Group Chief Executive comes from within the business. Marc is an outstanding leader and I look forward to working with him to ensure a smooth handover."

Marc said: "I am delighted to have been selected as Halma's next Group Chief Executive. I am excited by the opportunity to lead such a fantastic and talented team, and to continue Halma's long track record of creating value through our Sustainable Growth Model."

For further information, please contact:

Halma plc

Andrew Williams, Group Chief Executive +44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer and Chief Executive Designate

Charles King, Head of Investor Relations +44 (0) 7776 685948

Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013

MHP Communications

Andrew Jaques / Rachel Farrington +44 (0)20 3128 8404

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

· Safety: protecting life as populations grow and protecting worker safety.

· Environment: addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.

· Health: meeting rising healthcare demand as growing populations age and lifestyles change.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

In January 2022, Halma was named one of Britain's Most Admired Companies by Management Today.

 

NOTES

The person responsible for arranging the release of this announcement on behalf of the Company is Mark Jenkins, Halma's Company Secretary. 

The LEI of the Company: 2138007FRGLUR9KGBT40

REMUNERATION DISCLOSURES

Marc Ronchetti Effective today, Marc Ronchetti will receive a base annual salary of £700,000 as Chief Executive Designate to 31 March 2023. His bonus and executive share plan percentages remain at 180% and 250% of salary respectively and all of his other benefits remain the same. From 1 April 2023, when he assumes the role of Group Chief Executive, his base annual salary will increase to £900,000 per annum and his bonus, shares awards and benefits will be at levels commensurate with the Group Chief Executive role, as set out in the Remuneration Policy agreed by shareholders at the 2021 Annual General Meeting.

There is no additional information to be disclosed pursuant to LR 9.6.13 R.

Andrew Williams Termination arrangements will be in line with Halma's shareholder-approved Remuneration Policy and, in accordance with section 430(2B) of the Companies Act 2006, will be fully disclosed in our 2023 Annual Report and Accounts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUNUVRUKUNARR
Date   Source Headline
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.